| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
GliomaCarmustineTemozolomideInsula (Neuroanatomy)IDH1 Isocitrate dehydrogenase1 NADP solubleIDH2Neoplasia (Tumor biology and immunology)| 1 | 2007 | The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 11(45):iii-iv, ix-221 (2007) |
| 2 | 2001 | The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. |
| + | - | nl | Health Technol Assess 5(13):1-73 (2001) |
| 3 | 2009 | Targeted therapy in the treatment of malignant gliomas. | 
| + | - | nl | Onco Targets Ther 2(-):115-33 (2009) |
| 4 | 2010 | Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives. |
| + | - | nl | Target Oncol 5(3):183-91 (2010) |
| 5 | 2010 | Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas. |
| + | - | nl | Target Oncol 5(3):193-200 (2010) |
| 6 | 2010 | Targeted therapies on the horizon for malignant glioma. |
| + | - | nl | Target Oncol 5(3):157-60 (2010) |
| 7 | 2010 | Vascular endothelial growth factor inhibitors in malignant gliomas. |
| + | - | nl | Target Oncol 5(3):167-74 (2010) |
| 8 | 2010 | Targeting integrins in malignant glioma. |
| + | - | nl | Target Oncol 5(3):175-81 (2010) |
| 9 | 2010 | Molecular markers in gliomas: impact for the clinician. |
| + | - | nl | Target Oncol 5(3):201-10 (2010) |
| 10 | 2010 | Immune therapeutic targeting of glioma cancer stem cells. |
| + | - | nl | Target Oncol 5(3):217-27 (2010) |
| 11 | 2010 | Glioma stem cells as a target for treatment. |
| + | - | nl | Target Oncol 5(3):211-5 (2010) |
| 12 | 2010 | MGMT promoter methylation in malignant gliomas. |
| + | - | nl | Target Oncol 5(3):161-5 (2010) |
| 13 | 2007 | Lessons learned in the development of targeted therapy for malignant gliomas. |
| + | - | nl | Mol Cancer Ther 6(7):1909-19 (2007) |
| 14 | 2008 | Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. |
| + | - | nl | Ann Oncol 19 Suppl 2(-):ii83-5 (2008) |
| 15 | 2006 | Adjuvant treatment of high grade gliomas. |
| + | - | nl | Ann Oncol 17 Suppl 10(-):x186-90 (2006) |
| 16 | 2006 | Radiotherapy in malignant glioma. |
| + | - | nl | Ann Oncol 17 Suppl 10(-):x183-5 (2006) |
| 17 | 2002 | A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. |
| + | - | nl | Br J Cancer 86(4):501-5 (2002) Dinnes J |
| 18 | 2007 | Molecularly targeted therapy for malignant glioma. |
| + | - | nl | Cancer 110(1):13-24 (2007) |
| 19 | 2004 | Temozolomide in the treatment of recurrent malignant glioma. |
| + | - | nl | Cancer 100(3):605-11 (2004) |
| 20 | 2006 | Low-grade gliomas in adults. |
| + | - | nl | Oncologist 11(6):681-93 (2006) |
| 21 | 1999 | New treatment strategies for malignant gliomas. |
| + | - | nl | Oncologist 4(3):209-24 (1999) |
| 22 | 2009 | Angiocentric glioma: a case series. |
| + | - | nl | J Neurosurg Pediatr 3(3):197-202 (2009) |
| 23 | 2010 | Surgical management of World Health Organization Grade II gliomas in eloquent areas: the necessity of preserving a margin around functional structures. |
| + | - | nl | Neurosurg Focus 28(2):E8 (2010) |
| 24 | 2009 | Embryological development of the human insula and its implications for the spread and resection of insular gliomas. |
| + | - | nl | Neurosurg Focus 27(2):E2 (2009) |
| 25 | 2006 | Management of malignant glioma: steady progress with multimodal approaches. |
| + | - | nl | Neurosurg Focus 20(4):E3 (2006) |
| 26 | 2003 | Pathology of low-grade gliomas: an update of emerging concepts. |
| + | - | nl | Neuro Oncol 5(3):168-78 (2003) |
| 27 | 2001 | From the archives of the AFIP: superficial gliomas: radiologic-pathologic correlation. Armed Forces Institute of Pathology. |
| + | - | nl | Radiographics 21(6):1533-56 (2001) |
| 28 | 2006 | Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. |
| + | - | nl | Radiology 240(3):803-10 (2006) |
| 29 | 2010 | High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. |
| + | - | nl | Ann Oncol 21 Suppl 5(-):v190-3 (2010) |
| 30 | 2009 | Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. |
| + | - | nl | Ann Oncol 20 Suppl 4(-):126-8 (2009) |
| 31 | 2010 | Gliomagenesis and the use of neural stem cells in brain tumor treatment. |
| + | - | nl | Anticancer Agents Med Chem 10(2):121-30 (2010) |
| 32 | 2008 | Epigenetic changes in gliomas. |
| + | - | nl | Cancer Biol Ther 7(9):1326-34 (2008) |
| 33 | 2010 | Molecular diagnostics of gliomas: state of the art. |
| + | - | nl | Acta Neuropathol 120(5):567-84 (2010) |
| 34 | 2010 | Protein tyrosine phosphatases in glioma biology. |
| + | - | nl | Acta Neuropathol 119(2):157-75 (2010) |
| 35 | 2010 | Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. |
| + | - | nl | Radiology 254(3):876-81 (2010) |
| 36 | 2009 | Mutant metabolic enzymes are at the origin of gliomas. |
| + | - | nl | Cancer Res 69(24):9157-9 (2009) |
| 37 | 2010 | Gliomas in adults. |
| + | - | nl | Dtsch Arztebl Int 107(45):799-807; quiz 808 (2010) |
| 38 | 2009 | Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies. |
| + | - | nl | Expert Rev Neurother 9(12):1815-36 (2009) |
| 39 | 2007 | Insights into the cancer stem cell model of glioma tumorigenesis. |
| + | - | nl | Ann Acad Med Singapore 36(5):352-7 (2007) |
| 40 | 2007 | The role of surgery in high-grade glioma--is surgical resection justified? A review of the current knowledge. |
| + | - | nl | Ann Acad Med Singapore 36(5):358-63 (2007) |
| 41 | 2007 | Chemotherapy in adults with gliomas. |
| + | - | nl | Ann Acad Med Singapore 36(5):364-6 (2007) |
| 42 | 2009 | Molecularly targeted therapies for malignant gliomas. |
| + | - | nl | Mol Med 15(3-4):115-22 (2009) |
